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Abstract
EFFICIENCY OF THE THERMAL JACKET"' ON THE DEUVERED
TEMPERATURE OF PREWARMED CRYSTALLOID INTRAVENOUS
FLUID
Danny R. Bowen, BSN
School of Allied Health Professions--Virginia Commonwealth University, 1989.
Major Director:

John T. Beeston, BS, CRNA

A quasi-experimental research design was used to determine the
relationship between the flow rate and the delivered temperature of prewarmed
crystalloid intravenous solutions when using the Thermal Jacket111, an insulation
device designed for intravenous fluid bags, as compared to a conventional blood
warming apparatus.

One control and three experimental groups were used.

Fluids in Group 1 (control group), Group 2, and Group 4 were prewarmed
in a microwave oven to 41.45 ± 1.05

°

C.

Fluids in Group 3 were left near

ambient room temperature and measured at 22.05 ± 0.45

°

C.

Fluids in the

control group were infused through a standard intravenous pump tubing, 270 em
in length, using no temperature maintenance device.

Fluids in Group 2 and

Group 3 were delivered through a standard intravenous pump tubing connected
to a blood warming coil which was immersed in a water bath blood warmer.

The

distance from the exit point of the blood warmer to the distal end of the infusion
line measured 174 em.

Fluids in Group 4 were placed in a Thermal Jacket111 and

Vlll

delivered through standard intravenous pump tubing. After a baseline
measurement, temperatures were recorded for all groups at two sites at
intervals over a

60 minute period. One site was the lower portion of the

solution bag, and the other site was a point

2

em

IV

from the distal end of the

infusion set. Temperatures were measured at flow rates of
and

10 minute

100, 250, 500, 750,

1,000 ml/hr for each group.
Analysis of variance showed a highly significant group effect on the

delivered temperature. A Bonferroni multiple comparisons test indicated no
statistically significant difference between the delivered temperatures of Group 3
(room temperature fluid
Thermal Jacket"').

+

Group

blood warmer) and Group 4 (prewarmed fluid

2 (prewarmed fluid

significantly higher delivered temperature
control group (prewarmed

+

+

blood warmer) showed a

(p_ < .05) than the other groups, and the

no temperature maintenance device) showed a

significantly lower delivered temperature

(12. < .05). Analysis of variance also

showed a highly significant flow rate effect on delivered temperature.
Bonferroni multiple comparisons indicated a significant difference
between the flow rates of

+

A

(12. < .05)

100, 250, 500, and 750 ml/hr, with the higher flow rates

resulting in higher delivered temperatures. There was no significant difference
noted between the delivered temperatures at

750 and 1,000 ml/hr.

The Thermal Jacket"', used with prewarmed intravenous fluids, was as
effective as the conventional method of delivering warmed fluids. Also, within
the range of flow rates studied, faster flow rates tended to yield a higher
delivered temperature.

Chapter One

Introduction

Humans, as homeothermic animals, regulate body temperature by balancing
heat production with heat loss. This balance is controlled by centers in the
hypothalamus.

The body responds appropriately, under normal circumstances, to

temperatures above and below the set-point, or "normal" temperature range of

36.6-37.5

•

C (Berne &

Levy, 1983;

Cabanac,

1975;

Elder,

1984).

When the

body's core temperature rises above normal, it is considered to be hyperthermic;
when it falls below normal, it is considered to be hypothermic.
further classified as mild
or profound

(4-16.5

(34-36.5

·C) (Elder,

·C), moderate

(28-33.5

Hypothermia is

·C), deep

(17-27.5

·C),

1984).

Hypothermia affects all body systems to some degree.

Moderate to

profound hypothermia depresses cardiovascular function as evidenced by changes
in the blood pressure, pulse, and electrocardiogram.

It also depresses the

respiratory system and decreases the oxygen delivery to the peripheral tissues.
The central nervous system is depressed to the point of unconsciousness and renal
function is decreased to a degree which hinders clearance of toxic substances and
metabolic waste.

Enzyme and hormone activity are decreased as are normal
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clotting mechanisms. This degree of multisystem dysfunction is normally avoided
by appropriate physiological responses to hypothermia.
There are several factors related to anesthesia and the operating room
environment which could place every patient at risk for developing hypothermia.
The first of these is that anesthetic agents themselves interfere with the body's
normal response mechanisms to changes in temperature (Flacke, Flacke, Ryan, &
Britt, 1983; Lanning, Skulberg, & Abyholm, 1986; Vale, 1973).

Secondly,

intravenous fluids and blood products are often infused near or below room
temperature and contribute to hypothermia (Boyan & Howland, 1961, 1963;
Norman, Ahmad, & Zeig, 1986). The third factor is that anesthetic gases are
delivered cold and dry, leading to increased heat loss (Lilly, 1986; Yale, 1973).
The fourth mechanism is that the modem operating room is typically maintained
at an ambient temperature of 19-21 'C, which is well below body core
temperature.

This low temperature, coupled with the high air turnover,

contributes significantly to the development of hypothermia (Holdcraft & Hall,
1978; Lilly, 1986; Morris & Wilkey, 1970). Lastly, cold irrigation fluids are often
instilled in open body cavities and increase the heat loss during surgery (Goldberg
& Roe, 1966; Holdcraft & Hall, 1978).

Because the operating room environment, surgical procedures, and
anesthesia interventions potentially induce heat loss in many patients, the
anesthetist must take certain measures to avoid the development of hypothermia,
particularly in high risk patients.

Anesthetists employ active and passive

measures to prevent this heat loss.

Passive means of preventing hypothermia
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include increased ambient room temperature, liberal use of blankets and drapes,
the use of a heat and moisture exchange unit in the anesthesia breathing circuit,
and the use of warmed irrigation solutions (Elder, 1984; Goldberg, 1988; Haslam
& Nielsen, 1986; Lilly, 1986; Morris, 1971; Morris & Wilkey, 1970; Roizen,
L'Hornmedieu, Wylie, & Ota, 1980; Shanks, 1975).

Active means of preventing

hypothermia include warming-blankets, heated and humidified inspiratory gases,
warm gastrointestinal or peritoneal irrigation, radiant heat sources, and
extracorporeal heat exchange units.

One must remember, however that all of

these active means have inherent risks, complications, and inconveniences
(Conahan, Williams, Apfelbaum, & Lecky, 1985; Fried, Satiani, & Zeeb, 1986;
Goudsouzian, Morris, & Ryan, 1973; Harnett, Pruitt, & Sias, 1983; Morris &
Kumar, 1972; Papenburg, English, Foot, Farias, & Hinchey, 1987; Pickering,
Bristow, & Craig, 1977; Scott, 1967; Shanks, 1975; Stone, Downs, Paul, & Perkins,
1981).

Another popular active means of preventing hypothermia involves

warming all intravenous infusions.

This technique is effective when used alone or

in combination with other methods (Boyan & Howland, 1961, 1962, 1963;
Buckhold et al., 1978; Copping, Mather, & Winkler, 1972).

Warming is

accomplished by either the prewarrning of fluids or the infusion of fluids through
devices designed to warm them immediately before administration.

These blood

warming devices, though cumbersome, are effective within certain ranges of
infusion rates (Baker, 1985; Cooter, 1987; Ryrners, 1988).
Prewarming fluids is effective only as long as the heat can be retained by
the fluid prior to infusion.

A new device has been developed which potentially
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increases the length of time that a bag of intravenous fluid retains its original
prewarmed temperature without the use of bulky, cumbersome equipment.

Its

use with prewarmed fluids, therefore, may decrease both the incidence and
severity of hypothermia in the operating room setting. This device, the Thermal
Jacket'", is lightweight, easy to use, and potentially effective in infusing warmed
fluids to the surgical patient.

Statement of Purpose
The purpose of this study is to determine the relationship between the flow
rate and the delivered temperature of prewarmed crystalloid intravenous solutions
when using the Thermal Jacket'" as compared to a conventional blood warming
apparatus.

Statement of the Problem
Is there a difference between the Thermal Jacket'", used with prewarmed
intravenous fluids, and conventional warming methods in maintaining the
delivered temperature of crystalloid solutions at various flow rates in the
operating room environment?

Hypotheses
This study addresses the following hypotheses:
1) there will be no difference between the delivered temperatures of
prewarmed and room temperature fluids using a blood warmer apparatus;
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2)

there will be no difference between the delivered temperatures of room

temperature fluids using a blood warmer apparatus and prewarmed fluids using
no temperature maintenance device;

3)

there will be no difference between the delivered temperatures of room

temperature fluids using a blood warmer apparatus and prewarmed fluids using
the Thermal Jacket"';

4)

there will be no difference between the delivered temperatures of

prewarmed fluids using a blood warmer apparatus when compared with no
temperature maintenance device;

5)

there will be no difference be.tween the delivered temperatures of

prewarmed fluids using the Thermal Jacket"' when compared with no temperature
maintenance device; and

6)

there will be no difference between the delivered temperatures of

prewarmed fluids using the Thermal Jacket"' when compared with a blood
warmer apparatus.

Variables
Independent.

The independent variables were (a) the flow rate, and (b) the

temperature maintenance device.
Dependent.

The dependent variable was the delivered temperature.
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Definition of Terms
Flow rate.

Flow rate is the volume of fluid delivered via an infusion pump

expressed in milliliters per hour (ml/hr).

Flow rates in this study ranged from

100 ml/hr to 1,000 ml/hr.
Delivered temperature. Delivered temperature is the temperature of the
fluid, expressed in degrees Celsius ( C), at the distal end of the infusion tubing as
0

measured by an inline thermistor.
Prewarroed crystalloid solution. Prewarmed crystalloid solution is a
commercially prepared intravenous solution containing no oncotically active
substance.

Crystalloid solution in this study refers to lactated Ringer's solution in

1,000 milliliter (ml) bags warmed to approximately 42 ° C in a microwave oven.
Thermal Jacket"'. The Thermal Jacket"' is an insulation device for
intravenous fluid bags (Smith Medical Systems, Inc., Astoria, OR).
Conventional blood warming apparatus.

A conventional blood warming

apparatus consists of a heated, fluid-filled, metal heat sink, an associated fluid
warming coil immersed in the heated fluid, and a length of extension tubing
connecting the coil in the heat sink to the patient's intravenous catheter.

Assumptions
1. All infusion pumps will deliver the rate of flow at which they are set.
2. The thermometers will provide accurate readings of the temperature of
the fluids.
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Limitations
1.

Five thermometers were used in this study.

2.

Four infusion pumps were used in this study.

3.

Room temperature was set using a wall thermostat and measured, but

not controlled.

Conceptual Framework

Thermore�lation.

Homeothermic animals, such as humans, regulate their

body temperatures by balancing heat production with heat loss.

This balance

involves a complex set of responses which have been only partially delineated.

It

is known that mechanisms such as autonomic and behavioral responses play a
role in thermoregulation.
thermoregulation.

It is also known that there are three components to

These components are the afferent temperature sensors, the

efferent motor systems, and the control system.
The mechanisms involved in thermoregulation can be described in terms of
their responses to both increased and decreased body temperatures.

The

autonomic response to an increased temperature is stimulation of sweating and
dilation of cutaneous blood vessels.

Sweating increases heat loss by evaporation;

and cutaneous vasodilation increases heat loss by radiation.

Hormonal changes to

increased temperature include a decrease in thyroxine release by the thyroid
gland.

This decrease reduces metabolism, which in turn decreases heat

production.

Behavioral responses to increased temperature include change of

posture and avoidance of hostile temperatures.

The change of posture serves to
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increase the surface to mass ratio, and thereby increases the heat exchange
between the animal and the environment.
The autonomic response to a decreased temperature is piloerection and
constriction of cutaneous blood vessels. Piloerection forms a layer of air dead
space around the skin which decreases evaporative losses; and cutaneous
vasoconstriction reduces radiant heat loss. The hormonal response to a decreased
temperature is an increased output by the thyroid gland which increases
metabolism and thereby increases heat production. Behavioral responses to
decreased temperatures include a change of posture and avoidance of hostile
temperatures. The change of posture with decreased temperatures serves to
decrease the surface to mass ratio and decrease the heat exchange between the
animal and the environment (Berne & Levy, 1983; Flacke et al., 1983; Cabanac,

1975).
As previously stated, there are three components to thermoregulation.

Two

of these, the afferent temperature sensors and the efferent motor systems, are
regulated by the third, the control system. The afferent temperature sensors are
divided into the peripheral sensors and the central sensors.

It is estimated that

the central sensors are three times more predominant than the peripheral sensors
in humans (Cabanac, 1975). The most efficient responses to temperature
changes, however, have been found to occur when both central and peripheral
systems are intact (Downey, Miller, & Darling, 1969). The central sensors are
located in the anterior hypothalamus and the spinal cord. The peripheral sensors
are located nonuniformly in skin, mucosa, and some deep tissues.

It has been
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postulated that the uneven distribution of peripheral sensors suggests that
weighted integrated input from the peripheral sensors exists which determines the
sensitivity of the central regulatory system (Placke et al., 1983). This peripheral
regulation of the central sensors may account for the observation that the most
efficient responses occur when both systems are intact. The efferent motor
systems include heat generating mechanisms such as skeletal muscle activity and
heat dissipating mechanisms such as vasodilation. Although it is not the only
contributor, the hypothalamus seems to be the center of thermoregulation (Berne
& Levy, 1983; Cabanac, 1975). In addition to sensing temperature directly, it also

receives input from the afferent system and regulates the efferent system to
maintain a relatively constant temperature of 36.6-37.5

°

C. This set point

temperature is the critical temperature above which heat dissipation is activated
and below which heat generation and conservation are stimulated.
Pathophysiolo� of hypothermia. Hypothermia has a number of detrimental
effects on the normal physiology of the body. The cardiovascular, respiratory,
nervous, renal, endocrine, and musculoskeletal systems are all adversely affected
by hypothermia. These detrimental effects are a function of both the duration
and the degree of hypothermia (Elder, 1984 ).
The cardiovascular system is one of the major systems affected by
hypothermia. With core temperatures ranging from 33-35

°

C, there is an

increase in heart rate, central blood volume, and mean arterial blood pressure.
Cardiac output can increase up to 500% due to peripheral vasoconstriction
resulting from an increased level of catecholamines. At core temperatures of 30-
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33

°

C, there is a reflex decrease in heart rate, cardiac output, and blood pressure

(Elder, 1984; Lonning et al., 1986).

As the core temperature drops below 30

there is a propensity toward dysrhythmias.

°

C,

The electrocardiogram (ECG)

demonstrates these dysrhythmias, as well as other characteristic electrical changes
with an increasing magnitude of hypothermia. There are typically no changes,
except in rate, noted on the ECG, at temperatures above 33

°

C. Below this core

temperature there are increases in the P-Q and Q-T intervals, widening of the

QRS complex, bradycardia, and development of a J-wave, all associated with a
slowed myocardial conduction.

There is also an increased likelihood of

developing atrial fibrillation, atrial flutter, nodal rhythm, or second degree heart
block.

Below a core temperature of 30

°

C there is progressive widening of the

QRS complex and extreme bradycardia with frequent occurrence of ventricular
extrasystoles.

Atrial fibrillation typically occurs due to atrial distention, and as

the temperature continues to decrease, there is an increased incidence of more
fatal dysrhythmias. Below 27-29

°

C there is a high incidence of ventricular

fibrillation progressing to asystole at temperatures below 20

°

C (Churchill

Davidson, 1955; Elder, 1984; Little, 1959; Lonning et al., 1986).
The respiratory system also undergoes extreme changes in response to
hypothermia.

The initial response to core temperatures below 35

°

C is an

increased respiratory rate corresponding to an increased oxygen demand caused
by shivering. As the temperature falls below 33

°

C, there is a steady decrease in

the respiratory rate, approaching 1-2 gasps per minute at temperatures below
30

°

C. At these very low temperatures, there is an increased production of
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bronchial secretions with an increased incidence of bronchospasm.

Hypothermia

shifts the oxyhemoglobin dissociation curve to the left, decreasing the release of
oxygen from the hemoglobin molecule to the tissues. This effect on the
oxyhemoglobin dissociation curve is offset, somewhat, by a shift to the right
caused by metabolic acidosis.

Metabolic acidosis accompanies the peripheral

vasoconstriction seen with hypothermia.

Functionally, then, the oxyhemoglobin

dissociation curve changes have minimal consequences (Elder, 1984; Lilly, 1986;
Little, 1959; Lonning et al., 1986).
Other physiological systems show fewer, though no less profound, changes
with hypothermia. The central nervous system shows mental impairment below
33

°

C, progressing to a loss of consciousness below 30

activity on the electroencephalogram (EEG) below 20
1959; Lonning et al., 1986).

between 33

°

C and 35

°

°

°

C, and an absence of

C (Elder, 1984; Little,

The renal system demonstrates a "cold diuresis"

C due to the peripheral vasoconstriction associated with

hypothermia. As the core temperature drops below 33

°

C, there is a decreased

glomerular filtration rate which decreases the kidneys' ability to clear drugs and
their metabolites (Elder, 1984; Lonning et al., 1986).

With hypothermia comes

hyperglycemia and ketosis due to a decreased release of insulin from the pancreas
and a decreased insulin effect at the peripheral binding sites. There is also a
decrease in overall enzyme activity, with the brain being more sensitive than
other organs (Elder, 1984; Lonning et al., 1986). The musculoskeletal system
responds to hypothermia with vasoconstriction and shivering.

Below 33

°

is decreased shivering and a general stiffness of muscles and joints due to

C there
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muscular dysfunction as a result of impaired conduction in the peripheral nerves
(Little, 1959; Lonning et al., 1986). There is a progressive prolongation of the
clotting time, along with other coagulation defects, accompanying increased levels
of hypothermia (Churchill-Davidson, 1955; Lonning et al., 1986).
It is evident that as the degree of hypothermia increases, the degree of
dysfunction in most systems of the body increases.

Though some of these may

be beneficial, the overall effect of hypothermia is a deleterious one which
requires countermeasures to avoid eventual death.
Hypothermia durin� anesthesia. Hypothermia during anesthesia and surgery
is common.

Two factors which contribute to intraoperative hypothermia are the

nature of the operating theater environment and the effects of anesthesia on
thermoregulation. There are four mechanisms for this heat loss in the
anesthetized patient: (a) conduction, (b) convection, (c) radiation, and (d)
evaporation.

Conduction is the transfer of heat from the body to colder surfaces

which it contacts.

Convection is the heat loss to cooler, surrounding air currents

and can be thought of as the wind chill factor.

Radiation is the heat loss that

occurs between objects of different temperatures not in contact with each other.
The body radiates heat from uncovered areas, especially the scalp and upper
torso.

Evaporation is the loss that occurs when the skin and mucus membranes

provide heat to transform liquid water to a gaseous state.
The first factor contributing to intraoperative hypothermia is the operating
room environment.

The typical operating suite is conducive to heat loss leading

to hypothermia. The ambient room temperature is commonly maintained at 19-

13
21 ° C, primarily for the comfort of the surgical team. At those temperatures,
without any measures taken to avoid heat loss, most patients will become
hypothermic (Morris & Wilkey, 1970).

Even at temperatures as high as 24 ° C,

many patients still become hypothermic (Holdcraft & Hall, 1978; Lilly, 1986).
Much of the heat loss can be accounted for solely by the ambient temperature.
This is demonstrated by the greatest amount of heat loss occurring in the first
hour in the operating room and in the time between skin closure and delivery to
the recovery room.
There are, however, factors other than room temperature that contribute to
hypothermia.

Modern operating rooms have a high air turnover which increases

the likelihood of convective heat loss.

The operating table, unless heated, will be

near room temperature, and this increases the conductive heat loss.

Irrigation

fluids are frequently used at room temperature and this increases both conductive
and convective heat loss.

Another common factor is the increased surface area

available for conductive, convective, and radiative heat losses when the integrity
of the skin is interrupted by the surgeon's knife.

All of these make the modern

operating suite an ideal location for induction of unintentional hypothermia.
The second factor contributing to intraoperative hypothermia is the effect of
anesthetic agents on thermoregulation.

While the operating room environment

disrupts the balance of thermoregulation, anesthesia tips the scales in favor of
hypothermia.

Many of the anesthetic agents administered impair the

compensatory mechanisms normally used by the body in thermoregulation.

Many

anesthetics cause cutaneous vasodilation, reduce thermogenic shivering, lower the
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basal metabolic rate decreasing heat production, or act directly to impair the
temperature regulation center in the hypothalamus (Flacke et al., 1983; Lonning
et al., 1986; Yale, 1973).
Even the intravenous fluids administered increase the risk of developing
hypothermia.

Intravenous fluids are usually infused at room temperature which

may be almost 20

°

C lower than the core temperature of the body. Blood is

typically infused at even lower temperatures. Blood is stored at 4-6

°

C and,

other than incidental warming, is infused near that frigid temperature. Cold, dry
anesthetic gases are administered to the patient which cause evaporative and
convective heat loss (Lilly, 1986; Yale, 1973). The combination of anesthesia and
operating theater environment set the scenario for a hypothermic patient,
especially if that patient is already at risk for development of hypothermia.
There are a number of patient characteristics which have been found to be
related to an increased incidence of hypothermia.

People at either extreme of

age, namely young children and elderly adults, tend to have a higher incidence of
hypothermia during anesthesia.

The explanation for this, as well as an increased

incidence of hypothermia in cachectic patients, seems to be related to decreased
muscle mass, less vigorous shivering, and a resultant decrease in heat production.
Patients with massive injuries, exhaustion, and undernourishment also have a
decreased ability to produce heat; therefore, they have an increased risk of
developing hypothermia (Lilly, 1986; Lonning et al., 1986; Roe, Goldberg, Blair,
& Kinney, 1966).
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There are also a number of characteristics associated with the surgery and
surgical requirements that increase the incidence of hypothermia. Any procedure
requiring the opening of any major body cavity increases the risk of hypothermia
as does any procedure which necessitates infusion of large volumes of fluid or
blood. (Goldberg & Roe, 1966; Lilly, 1986). As stated before, ambient
temperature plays a major role in hypothermia, so any surgical condition which
requires low ambient temperatures will put the patient at risk for heat loss.
Patients who have substantial heat loss during surgery must regain this heat
in the postoperative period.

Unfortunately, those patients at increased risk for

development of hypothermia are also those least capable of recovering the lost
heat by increasing heat production in the postoperative period.

For example,

elderly patients have been found to require twice as much time to return to their
preoperative temperatures when compared to younger adults, even though their
immediate postoperative temperatures may be similar (Vaughn et al., 1981).
Prevention of hwotherrnia.

Since hypothermia in the operating room is

quite common, a number of measures have been utilized to prevent or counter
heat loss. These methods can be divided into two broad categories: passive and
active warming.

In the first of these, passive warming, the patient's endogenous

heat production is the source of thermal energy and is augmented by decreasing
the heat loss. Passive measures are typically easy to apply and have minimal risks
associated with them. One passive method is to increase the ambient
temperature at least until the patient is prepped and draped. At room
temperatures above 24 · C very few patients will become hypothermic, whereas, at
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temperatures below 21

°

C almost all patients become hypothermic (Morris, 1971;

Morris & Wilkey, 1970; Roizen et al., 1980).

Another passive method is covering

as much of the patient as is practical with some type of insulating material.

This

material can be towels, cotton blankets, mylar-aluminum "space blankets", or even
aluminum foil or plastic wrap. The most important areas to cover are the head,
neck, and shoulders because these areas maintain perfusion even when the core
temperature drops (Elder, 1984; Ully, 1986; Shanks, 1975).

A third passive

method of decreasing heat loss is the use of a heat-moisture exchange unit
("artificial nose") inserted between the anesthesia breathing circuit and the
endotracheal tube (Goldberg, et al., 1988; Haslam & Nielsen, 1986).

This

decreases the energy required to warm and humidify the cold, dry gases
administered to the patient (Ully, 1986). The fourth passive method is the use of
warmed irrigation solutions during surgery. These passive methods are relatively
easy to employ, cost effective, and generally risk free.
The second category of preventing or countering heat loss is active warming.
With these measures, external energy is supplied to supplement the patient's own
heat production.

Active methods are usually more involved and potentially more

dangerous than passive means.

For example, the seemingly innocuous use of a

warming-blanket can be hazardous.

With warming blanket temperatures of 40-

42 ° C serious thermal injuries have been reported (Scott, 1967).
Use of warming blankets is widespread in spite of studies which have shown
them to be potentially dangerous as well as ineffective in preventing or reversing
hypothermia in patients weighing more than 10 kg (Goudsouzian et al., 1973;
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Morris & Kumar, 1972; Stone et al., 1981). Another active method, heating and
humidifying of inspiratory gases, has been shown to be effective in preventing and
even in reversing hypothermia (Conahan et al., 1985; Shanks, 1975; Stone et al.,
1981).

This method, however, can cause thermal damage to the respiratory

mucosa as well as potential overhydration due to the volume of fluid
administered in the humidified gases via the breathing circuit (Harnett et al.,
1983).
Gastrointestinal warming is another active method used to prevent or
counter hypothermia.

With this method, gastric lavage is accomplished with

warm irrigation fluid.

Gastrointestinal warming has the advantage of applying

heat directly to the core of the body without penetrating any tissues.

The only

risk involved with this method is mechanical trauma from the insertion of the
irrigation tube.
A fourth method is the use of a radiant heat source. This is acceptable in
the recovery room, but, because of the request from the surgical team for cooler
ambient temperatures; this method is not practical except for infants (Flacke et
al., 1983; Lilly, 1986).
The fifth and sixth methods are peritoneal irrigation with warmed fluid and
warming the patient's blood using an extracorporeal heat exchanger. These two
methods have been used to reverse profound hypothermia, and therefore, could
be used to attenuate the heat loss during surgery, but their use is neither practical
nor risk-free.

Both methods are fast and both can include dialysis of toxic

substances from the blood. These advantages make their use more suited for an

18
emergency department than an operating room. Both have many inherent risks,
and are, therefore, not useful in routine operating room circumstances (Fried et
al., 1986; Harnett et al., 1983; Papenburg et al., 1987; Pickering et al., 1977).

The final active method of preventing hypothermia concerns the warming of
all fluids and blood products infused during surgery.

This has been found to

prevent and even reverse hypothermia, even in patients receiving 18 or more
liters of fluid and blood over a few hours (Boyan & Howland, 1961, 1962, 1963;
Buckhold et al., 1978; Copping et al., 1972).

Effects of Blood Warming
The deleterious effects of cold blood infusion were seemingly not
appreciated until the mid 1950s. In 1955, Howland, Schweizer, Boyan, and Datto
published a study concerning the physiologic alterations resulting from massive
blood replacement. This study looked at two groups of patients who received
multiple transfusions during the course of surgery.
In group one

(!!

=

blood, and in group two

130), each patient received 10 or more units of citrated

(n

=

123), each patient received 5-9 units of citrated

whole blood. In group one, there was a 43% incidence of one of two major
complications. The first complication concerned a defect in the clotting
mechanism. This defect appeared to be directly related to the volume of blood
administered. The second major complication involved the cessation of cardiac
function in 22 patients, all of whom received more than 10 units of blood. In the
11 patients monitored by electrocardiography, these cardiac dysfunctions were
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identified as either ventricular fibrillation or asystole. The incidence of these
dysfunctions appeared to be correlated not with the volume of blood
administered, but with the speed of blood administration.

It was concluded, "the

exact mechanism by which rapid transfusion of large quantities of citrated blood
produces either cardiac standstill or ventricular fibrillation is still in doubt ..."
(Howland, Schweizer, Boyan, & Dotto, 1955).

Hyperkalemia or citrate

intoxication with resultant hypocalcemia was thought to play a role in the cardiac
dysfunction.
Interestingly, the authors stated "marked cooling of the viscera is a fact
observed by many surgeons after massive blood replacement and is usually
premonitory of impending disaster" (Howland et al., 1955). The authors also
noted that a direct correlation between the degree of cooling and the onset of
ventricular fibrillation appeared to exist. Cooling, however, was not listed as a
possible major factor in the complications studied.
In 1956, three of the same authors, Howland, Boyan, and Schweizer,
examined ventricular fibrillation during massive blood replacement. In this study
of 253 patients who received 2,500 ml or more of citrated banked blood, nine
instances of ventricular fibrillation were noted. Six of these instances of
ventricular fibrillation occurred in patients who had received more than 5,000 ml.
The most consistent factor in the development of ventricular fibrillation was
found to be rapid, intravenous, citrated blood replacement.

It was concluded,

however, that this rapid rate of administration was not the only factor responsible.
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Other possible factors contributing to cardiac dysrhythmias included
hyperkalemia, citrate intoxication, pH of the blood, and, more importantly,
hypothermia. The authors proposed that infusion of cold, banked blood resulted
in a stream of cold blood being delivered directly to the right side of the heart
and concluded "it is possible that this cooling of the myocardium may lead to
cardiac arrhythmias and ventricular fibrillation" (Howland, Boyan, & Schweizer,

1956). Also noted were classic alterations in the electrocardiogram which have
since been associated with hypothermia such as peaked, elevated T waves,
prolonged Q-T interval, and wide, bizarre QRS complexes.

In conclusion, the

authors speculated that lowered myocardial temperature may be one of the
etiologic factors in the development of ventricular fibrillation.
In

1961, Boyan and Howland examined the relationship between the

temperature of administered blood, the patient's esophageal temperature, and
physiological response.

In this study, a thermocouple was inserted into the

esophagus of patients to a point behind the right atrium to attain approximate
cardiac temperatures. Two patients received
of cold banked blood at

6,350 ml and 21,000 ml, respectively,

6,600-9,000 ml/hr and demonstrated progressive cardiac

dysfunction. The first signs of cardiac change were noted at

29-33

°

C. These

signs consisted of prolongation of the ST interval, bradycardia, ventricular
extrasystoles, and hypotension. At
Boyan and Howland

29.8-32

°

C all cardiac function ceased.

(1961) reported the first clinical use of a blood

warming apparatus. Three patients received
through a blood warmer at a rate of

7,800-9,600 ml of 33-35

°

C blood

3,600 ml/hr. Temperatures for the three
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patients remained above 35.7

•

C and none exhibited signs of cardiac dysfunction.

The authors concluded that cardiac difficulties associated with massive blood
replacement could be related to the degree of hypothermia of the heart.
All of the studies reviewed up to this point have been anecdotal or

descriptive and have not provided statistical analyses nor specific methodologies.
These researchers merely identified the occurrence of hypothermia as a result of
cold, banked blood administration without utilizing true or quasi-experimental
methodologies to validate their findings.
In 1963, Boyan and Howland reported a retrospective, nonrandornized study
of 81 patients who received 3,000 ml or more of blood, cold or warm, at rates of
at least 3,000 ml/hr.

Of the 36 patients who received cold blood, 25 had infusion

rates of 3,000-6,000 ml/hr and 12 of these experienced cardiac arrest in the
operating room. The remaining 11 patients received cold blood at greater than
6,000 ml/hr and 9 experienced cardiac arrest in the operating room. There were
45 patients who received blood via the warming device.

Of these, 40 received

blood at 3,000-6,000 ml/hr and none of these experienced cardiac arrests. The
remaining five patients received warmed blood at rates exceeding 6,000 ml/hr
and only one patient experienced a cardiac arrest in the operating room.
The authors found a statistically significant

(�

=

29.0, 12 < .01) higher

incidence of cardiac arrest in those patients receiving cold blood when compared
to those receiving warm blood. A statistically significant

(�

=

20.4, 12 < .01)

higher incidence of cardiac arrest was also found in patients receiving blood,
warm or cold, at rates greater than 6,000 ml/hr as compared to those receiving
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blood at rates of 3,000-6,000 rnl/hr. The authors attributed part of these
differences in the cardiac arrest incidence to the patient's condition since the
patients who required rapid administration were most likely experiencing
problems not controlled for in this retrospective study.
In 1964, Boyan reported on an additional number of patients who received
blood via the blood warming device and statistically reexamined his 1963 study to
include these patients.

This study, as the first, was retrospective and

nonrandomized. The same cold blood infusion group was used as before and
more warm blood infusion patients were added to bring the total to 118 patients
who received blood via the blood warming device. Once again a statistically
significant difference

(�

=

44.5, 12. < .01) was found between the warm and cold

groups with the patients receiving cold blood demonstrating a higher incidence of
cardiac arrest in the operating room. A statistically significant difference

(�

=

35.7, 12. < .01) was also found between the patients receiving blood at 3,000-

6,000 ml/hr as compared to those receiving blood at greater than 6,000 ml/hr.
As before, the faster infusion group demonstrated a higher incidence of cardiac

arrest. All patients included since the previous study received blood via the
blood warmer.

No additional patients were infused cold blood. The author

failed to discuss any changes in the patient population, criteria used for blood
administration, surgical technique changes, or other factors that may have
accounted for decreased morbidity and mortality.
In 1986, Fried et al. reported on a rapid solution administration set (RSAS).
This study described the in vivo use of the RSAS on one mongrel dog. The dog
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was anesthetized, exsanguinated of

1,200

rnl of blood, and then administered the

ml of autologous blood via the RSAS at

the dog was again exsanguinated of

1,200

1,200

ml of

4

1,200

43,800

ml/hr.

After

74

minutes,

ml of blood and then administered

day old homologous blood via the RSAS at

42,600

ml/hr.

Hemodynamic measurements, a battery of laboratory tests, and vital signs were
recorded throughout the study period.
Hemodynamic parameters, laboratory values, and vital signs were reported
in a table without statistical analyses.

On visual inspection, it appeared that post

infusion values of all parameters measured were essentially the same as baseline
measurements.

The dog's temperature never fell more than

baseline temperature.

1.2

'C below its

The authors then concluded that this device is probably

effective in maintaining normothermia in a trauma patient.

This appeared to be

a rather strong generalized conclusion from a study that (a) involved one mongrel
dog, (b) made no statistical analysis, (c) involved no control group, and (d) made
no mention of the setting where the study took place or to any control of other
variables.

For example, there was no mention of the ambient room temperature.

Many studies have found ambient room temperature to be a significant
contributor to maintenance of normothermia in surgical patients.

Effects

of CQ'stalloid Warmin�

Newman

(1971)

reported a nonrandomized, controlled study of

33

patients

receiving one of three interventions to prevent the development of hypothermia
during surgery.

Patients in Group I (Control group) were operated on without
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any attempt to control their temperatures.

Group II patients were placed on a

warming blanket (40-42 ·C) throughout the operation, and Group III patients
were placed on a warming blanket and given warmed (37 ·C) intravenous fluids
and blood.

Esophageal temperatures were measured every 15 minutes after

induction of anesthesia.
Fourteen of the 15 patients in Group I had a 2.0-4.6

•

C decline in

esophageal temperature. The remaining Group I patient had a 0.8 ·C fall in
temperature throughout the surgery.
demonstrated a 0.5-2.0

•

C decline in temperature during the surgery while the

remaining patient had a 0.2
Group ill ranged from a 0.5
in temperature.

Seven of the eight Group II patients

•

C increase in temperature. The 10 patients in
•

C drop in esophageal temperature to a 1.3 • C gain

Visual examination of the data indicated that the warming

blanket alone decreased the heat lost during surgery, and when combined with
infusion of warm intravenous fluids, made the heat loss negligible. No definite
conclusions can be reached, however, since no statistical analysis was reported.
Copping et al. (1972) reported a nonrandomized, controlled study of 16
mongrel dogs that were placed in controlled, hemorrhagic shock and subsequently
volume repleted with lactated Ringer's solution at various temperatures. Group I

(n

=

5) received infusions of fluids cooled to 4.5 ·C.

Group II

(n

=

6) served as

a control group and received infusions of fluids at a room temperature of 21.026.7 ·C. Group III

(n

=

5) received infusions of fluids warmed to 37 0
.

•

C and

infused at 33.3-34.4 ·C. All solutions were infused at 3,000 rnl/hr and all groups
received similar volumes of intravenous fluid. Results of mortality rates,
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esophageal temperatures, pulse changes, and ECG changes were presented, but
analysis of data was confined to descriptive statistics. It appeared that the degree
of hypothermia, cardiovascular changes, and mortality all increased as the
infusion temperature decreased.

While the study seemed to have controlled

extraneous variables and demonstrated differences, it failed to provide statistical
analyses to support any findings.

Sumroacy
As we have seen, the detrimental effects of rapid, cold blood administration

has been recognized since the late 1950s. Since that time, various methods of
warming blood have been investigated.

Researchers then studied the effects of

administering warmed intravenous fluids.

From this line of research, it would

appear that the use of various blood warming devices for warming both blood
and crystalloid fluid plays a major role in decreasing both morbidity and mortality
resulting from hypothermia.
Jacket"'.

One new concept in fluid warming is the Thermal

Until now, no formal research has been done concerning its

effectiveness in delivering warmed fluid.

Chapter Two

Review of Literature

Methods of Warmin� Blood and Crystalloids
A number of methods have been utilized in delivering warmed fluids and
blood to the surgical patient. The first of these was first developed and reported
in

1961 by Boyan and Howland. This blood warmer consisted of 24 feet of 4.5

mm diameter plastic tubing wrapped around a wire frame and immersed in a 20
liter water bath. The water in the bath was maintained near 37 · C by adding hot
or cold water and was monitored using a bath thermometer. The one safety
feature, a thermocouple, activated a warning light if the temperature in the bath
exceeded 37 ·C. Though bulky and cumbersome to use, this first blood warmer
was an improvement over cold blood administration. At flow rates of 3,000
ml/hr this device warmed blood from a storage temperature of 4-6

•

C to 35 ·C.

The warmer was less efficient at flow rates of 6,000 ml/hr, warming the cold
blood to 33 ·C. At higher flow rates of 7,200-9,000 ml/hr, the device was only
able to warm the blood to 30.6-32 ·C.
Baker (1985) investigated the effect of flow rate on heat loss in packed red
blood cells warmed using a modern blood warmer (DUPACO,
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Hemokinetitherm®) with a bath temperature maintained at

33-34

·C.

In an

operating room with an uncontrolled ambient temperature measured at

18.7

•

C, flow rates of the blood were manipulated over a range of

ml/hr.

16.2-

50-4,000

Temperatures were measured at both the inlet and outlet ports of the

blood warmer and again at the distal end of the infusion set. The blood used was
initially near room temperature rather than at a typical storage temperature of

4

•

c.
Baker

( 1985)

found that at flow rates below

500

ml/hr, the delivered

temperature of the blood was lower than the temperature at the inlet port of the
blood warming unit.

It was proposed that this heat loss may have been due to

the colder temperature of the air near the floor, where the blood warmer was
placed, and its effect on convective heat loss of the system. The use of the blood
warmer at these flow rates may be counterproductive to the desired effect of
delivering warmed fluids to the patient.

At flow rates of

500-3,000

ml/hr there

was a nonlinear, positive correlation between the flow rate and the delivered
temperature of the blood indicating an ability to overcome convective heat losses
that the slower flow rates experienced.

Within this range, the faster flow rates

resulted in higher delivered temperatures.

At flow rates exceeding

there was a steady decline in the delivered temperature.

3,000

ml/hr

These flow rates, it was

suggested, may have exceeded the heat transfer capabilities of the system used.
Based on these findings, it was concluded that at flow rates between

500-3,000

ml/hr the system was effective in increasing the delivered temperature of room
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temperature, banked blood.

It was also concluded that outside of this flow rate

range the system became ineffective and even counterproductive.
Cooter (1987) studied the Fenwal Dry Heat® blood warmer using a
methodology similar to Baker's (1985), but with the following improvements: (a)
the storage temperature of the blood was maintained at 1.2-4.3

°

C before

infusion; and (b) the blood warming device used was mounted on a pole next to
the patient potentially, eliminating the high convective loss near the floor of the
operating room.

Flow rates of 100-8,000 ml/hr were used and were compared to

the delivered temperature.
higher flow rates.

Additional infusion pumps were added to achieve

Uncontrolled room temperature was measured at 19.8-20.8

°

C.

It was found that the delivered temperature of the blood rose continually
from flow rates of 100 ml/hr to 1,000 ml/hr.

There was a decline in the

delivered temperature from flow rates of 1,100 ml/hr up to 1,900 ml/hr, and then
another steady increase in delivered temperature at flow rates of 2,000-7,992
ml/hr.

Cooter concluded that the Fenwal Dry Heat® blood warmer became more

effective as flow rates increased, and was more effective at high flow rates than
the blood warmer used by Baker (1985).
What Cooter (1987) did not address was the presence of variations in the
expected delivered temperatures at several flow rates.

For example, decline in

delivered temperature from 1,100-2,000 ml/hr was noted, but not the peaks
representing maximum differences from predicted temperatures at about 1,000,
2,000, 3,000, 4,000, 5,000, 6,000, 7,000, and 8,000 ml/hr.

On inspection, it

appeared that these maximum differences occurred at flow rates corresponding to
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the maximum output of these pumps or at points in the study when new pumps
bad to be added to the system.

The reason for addition of new pumps is that

each Travenol volumetric infusion pump used was only capable of administering
fluids up to 999 rnl/hr.

As the experimental flow rate increased, it became

necessary to connect additional pumps to accommodate this increase.
Rymers (1988) studied a DUPACO, Hemokinetitherm® blood warmer
similar to that investigated by Baker (1985). This study examined the effect of
flow rate and intravenous tubing length on the delivered temperature of warmed
packed, red blood cells. The heat loss at low flow rates in Baker's (1985) study
was attributed to conductive losses caused by contact between the infusion tubing
and cold surfaces in the study environment.

Improving on the methodology used

by Baker, Rymers ensured that no part of the infusion tubing carne in contact
with any non-insulated object.

With this modification, delivered temperatures

were higher at all flow rates than temperatures at the inlet port of the blood
warmer.

The delivered temperature increased from flow rates of 100 rnl/hr to

3,100 rnl/hr at which time a steady state was reached with similar delivered
temperatures being attained up to 5,700 rnl/hr. Above this flow rate, a decline in
delivered temperature was noted. It was also found that the greater the length of
the infusion tubing, the more heat was lost between the blood warmer and the
distal end of the infusion set.

As with Cooter's (1987) study, Rymers' data

showed fluctuations in the curve representing the relationship between flow rate
and temperature at flow rates near the points where additional infusion pumps
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had to be added.

These fluctuations and relationships were not addressed in the

discussion.
Zorko and Polsky (1986) investigated yet another method of delivering
warmed blood to the surgical patient. This study was designed to examine the
flow rates of blood delivered at various temperatures and through various circuits.
The delivered temperature of blood, stored at 4
research groups, was compared.

°

C and divided into four

In the control group

(1),

blood was infused

through a blood administration set using no warming method.

In a second group

(II), stored blood was warmed using a Travenol blood warming coil and
Hemokinetitherm® blood warmer. A third group (III) used the same infusion
tubing as the control group, but in this group, 250 m1 of 45
added to the packed, red blood cells just prior to infusion.

°

C normal saline was

The fourth group (IV)

combined both experimental methods (II & III) by adding warmed saline to the
blood and infusing it through the blood warming device.
It was pointed out that blood used in the control group was warmed to a
mean temperature of 18
set.

°

C as it traversed the length of the blood administration

The addition of warmed saline to the blood resulted in a mean delivered

temperature of 26

°

C.

Infusion of cold blood through a blood warmer yielded a

mean temperature of 29

°

C.

The combination technique of adding warmed

saline to the blood and infusing it through the warming device yielded the highest
mean delivered temperature of 35.3

°

C.

A number of possible problems exist in the methodology and conclusions.
First, the units of blood in the control group (I) and in group II, which used the
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blood warmer alone, were undiluted. Adding room temperature fluid to these
groups, as was done with groups III and IV, would possibly have increased the
initial blood temperatures above the stored temperature of 4

°

C. This would

have, therefore, decreased the difference in delivered temperatures between the
diluted and undiluted groups using the same method of delivery. Second, the
control group gained 14

°

C without any intervention.

An

additional group,

infusing unwarmed blood through a blood warming coil, but not using a blood
warmer, may have determined how much of the temperature gain in the blood
warming circuit was attributable to movement through the tubing exposed to
ambient room temperature. A final major problem area with this study was the
lack of flow rate control. Controlling the flow rate would have controlled the
length of time the blood was exposed to ambient room temperature, and
therefore determined the effect of room temperature exposure on delivered
temperatures. Though the study was designed to examine flow rates, controlling
the flow rates may have made the delivered temperature data more meaningful.
Aldrete (1985) compared the delivered temperatures of lactated Ringer's
solution infused at 6,000 ml/hr using one of three methods of warming the fluid.
In Group
36 ° C

1,

fluid was passed through a Goldman-Rupp blood warmer set at

using a 180 em intravenous tubing connected to the standard blood

warming apparatus for a total length of 375 em. Fluids in Group
in a Sears Kenmore"' microwave oven to 41.5
of tubing. Group

3

°

2

were warmed

C and delivered using only 180 em

used a combination of these two methods. Group 4, the

control group, consisted of room temperature fluid delivered through the 180 em
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tubing using no warming methods. The control group maintained an approximate
temperature of 18

•

C both in the bag and at the distal infusion site. The

unwarmed group using the blood warmer resulted in temperatures of 27
while the combination method (microwave warming
the delivered temperature to 30

•

+

·

C,

blood warmer) increased

C. The microwave warming alone, however,

produced the highest delivered temperature of 33-34

•

C.

Aldrete (1985) also examined the temperature of fluids in the bag and
delivered temperature of fluids at two flow rates.

It was found that fluid in the

bag and fluid delivered to the distal site both cooled more per volume infused
when the infusion rate was 1,200 ml/hr as compared to an infusion rate of 6,000
ml/hr.

A possible problem with this finding is that the rate of cooling was not

expressed in terms of time.

It would appear logical that the length of time fluid

is exposed to ambient room temperature could significantly effect the amount of
heat lost in the fluid.

Another possible shortcoming of this study was the lack of

recorded specific temperatures.
values.

Very few temperatures were reported as exact

Instead, most data was displayed in graphic form and showed only

temperature trends. Though trends are informative, specific data could provide
for statistical analysis.
Another method of fluid warming was investigated by Fried et al. (1986).
This study examined the efficiency of an extracorporeal heat exchanger when
used as part of a rapid solution administration set.

This set was designed to

administer large amounts of fluid quickly through a 8.5 French catheter.
countercurrent waterflow of 20 liters per minute at a temperature of 40

With a
•

C, blood
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was warmed from a storage temperature of

38-39

•

4 ·C

to a delivered temperature of

C. There was a detailed explanation of the equipment and materials used

to develop this administration set and a clear reporting of the findings.

This

study, however, used no control group and reported no statistical analysis of the
data.
Norman et al.

studied the effects of flow rate, time, and insulation on

(1986)

the delivered temperature of lactated Ringer's solution prewarmed in a warming
cabinet.

It was found that the higher the initial temperature of the solution, the

higher the delivered temperature at all time intervals.
ml/hr with an initial temperature of

33.9

•

C at

cabinet.

5

minutes and

28.0

prewarmed to

50.0

•

•

uninsulated fluids.

C at

5

minutes and

31.0

49.6

•

C bad

• C at one hour.

Fluids

C and insulated using foam rubber as an insulating material

bad a delivered temperature of

37.0 · C

which was approximately the same as the

However, at one hour, the insulated fluid had a higher

delivered temperature of

1

C at one hour after removal from the warming

•

37.2

1,000

• C had delivered temperatures of

At the same rate, fluids with an initial temperature of

delivered temperatures of

within

44.0

Fluids infused at

33.8

·C. The control group maintained temperatures

• C of ambient room temperature at all times measured.

It was concluded that at a slower rate of

500

ml/hr, fluids had to be

prewarmed to higher temperatures to have delivered temperatures approximating
the higher infusion rate groups.
temperatures of
temperature of

• C at

36.0

55.0

•

5

Fluids prewarmed to

minutes and

30.1

·C at

58.8
1

• C had delivered

hour.

With an initial

C, the slower rate resulted in a delivered temperature of
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28.9

•

C at 1 hour. As a result, it was demonstrated that insulation of prewarmed

bags of intravenous fluid helped maintain higher delivered temperatures
throughout the one hour trial.

It was also found that higher initial temperatures

and higher flow rates resulted in higher delivered temperatures at all times
studied.

Sununazy
The literature appears clear on the fact that administering cold intravenous
fluid and blood can induce hypothermia in surgical patients.

It also appears that

delivering warm fluids and blood can decrease this incidence of hypothermia with
its associated morbidity and mortality.

A number of methods have been used to

deliver warm fluids to the surgical patient. These methods can be grouped into
(a) those devices or methods which warm the fluid en route to the patient, and
(b) those methods or devices which warm the fluid prior to administration.

In

some instances, these methods have been combined with varying degrees of
effectiveness.
In all methods examined, there is an optimum delivery rate or range of rates
at which the particular method is most effective. The slower infusion rates seem
to be most susceptible to convective temperature loss from exposure to ambient
room temperatures.

This effect seems to be compounded when the infusion set is

increased in length.

Some studies find that prewarming fluids and delivering

them through a short infusion set is the most effective means of delivering
warmed fluids.

Additionally, some find that insulating the fluid container
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decreases the rate of heat loss and, therefore, increases the time the fluid can be
administered at an effectively high temperature.
A number of questions remain.

First, how effective is insulation in

maintaining the temperature of prewarmed fluids before administration?

Second,

what is the minimum flow rate at which fluids can be administered, using the
various methods, to maintain

an

adequate delivered temperature?

Third, is there

a safe, inexpensive, and simple method of delivering fluids to a surgical patient at
or near body temperature?

Chapter Three

Methodology

Design
To answer the question, is there a difference between the Thermal Jacket"'
and conventional means in maintaining the delivered temperature of prewarmed
crystalloid solutions at various flow rates in the operating room environment, a
quasi-experimental design was used.

The independent variables--flow rate and

temperature maintenance device--were manipulated while the dependent variable
-delivered temperature--was observed. Time was treated as a fixed variable.
There were three experimental groups and one control group.

In the control

group, no temperature maintenance device was employed.

Population and Sample
The population consisted of all Thermal Jacket"' insulation devices and all
Hemokinetitherm® fluid warmers. The Thermal Jacket"' used for this study was
obtained from the manufacturer and the Hemokinetitherm® was obtained from an
operating room currently using this warmer. The Thermal Jacket"' was a quilted,
wrap-around, insulation device which enclosed bags of intravenous fluid and was
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secured by Velcro straps.

The Thermal Jacket"' depicted in Figure 1 appears in a

closed configuration.

!:
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Figure 1.

Thermal Jacket"' intravenous insulation device.

Treatment Groups
Group 1 was the control group.

Intravenous (IV) fluids in this group were

prewarmed and infused using no temperature maintenance device.
Group 2 consisted of prewarmed IV fluids infused through a water bath type
blood warmer.
Group 3 consisted of IV fluids near 21 • C (ambient room temperature) and
infused through a water bath type blood warmer.
Group 4 consisted of prewarmed IV fluids infused using a Thermal Jacket'"
insulation device.

38

Procedure
Attempts were made to replicate a typical operating room environment with
the exception of a patient and the surgical team.

Doors to the operating room

were closed, room lights were on, and surgical lamps were lit and focused on the
center of the operating room table which was located at approximately the center
of the room.

Ambient room temperature was set at the wall thermostat to 21 ° C

and measured throughout the study.

All anesthesia equipment normally present

in the room was turned on.
The blood warmers were placed near the head of and on opposite sides of
the operating table and were filled with sterile water to the manufacturer's
specifications.

A 30 minute equilibration time was allowed prior to data

collection to allow stabilization of the water bath temperature. The bags of fluid
were hung at 200

em

from the floor and measures were taken to avoid contact

between the bags, any part of the infusion sets, and other uninsulated surface or
object. All infusion pumps were attached to IV poles 120 em from the floor with
a minimum distance of 50 em between them.

The infusion setup is depicted in

Figure 2.
One liter Viaflex'" (Fenwall Laboratories, Division of Travenol Laboratories,
Incorporated, 1 Baxter Parkway, Deerfield, Illinois, 60015.) plastic containers of
lactated Ringer's solution used for Groups 1, 2, and 4 were prewarmed to
approximately 42

°

C by heating in a microwave oven set to maximum power for
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A

Infusion set as used with Group 2 and Group 3.

B.

Infusion set as used with Group 1 and Group 4.

IP. Infusion pump.
BW. Hemokinetitherm® Blood Warmer.
Tl. Temperature measurement site inside the bag of intravenous fluid.
T2. Distal temperature measurement site.

Figure 2. Infusion setup.
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two minutes. The same type fluid was stored at room temperature and used for
group 3.
Identical standard intravenous pump tubing was used for all groups.

Groups

2 and 3 incorporated a blood warming coil attached to the distal end of the pump
tubing and immersed in a preheated blood warmer according to the
manufacturer's specifications.

The intravenous pump tubing and blood warming

coils were not modified from their normal length.

The distal end of each infusion

set was secured with tape to a piece of foam rubber on the operating table 90 em
from the floor and allowed to drain into a collection container.
After a baseline measurement, temperatures were recorded at 10 minute
intervals over a 60 minute period at 2 different sites for each group.

The first

site measured was in the lower portion of the IV solution bag. This was
accomplished by inserting a Mon-A-Therm® temperature probe through the
rubber medication port in the bottom of the container.

The second site was 2 em

from the distal end of the infusion set and was measured using a Mon-A-Therm®
inline thermistor. Temperatures were measured at flow rates of 100, 250, 500,

750, and 1,000 ml/hr for each group.

Room temperature was recorded at the

same time intervals, and to decrease any variation that room temperature may
have had, all groups were run simultaneously at each flow rate.

Instrumentation
Fluid Warmer. The DUPACO Hemokinetitherm® Model #32400 Fluid
Warmer was used.

It is an automatic system regulated by a proportional
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controller which, according to the manufacturer, maintains a precise temperature
in the 550 ml water reservoir between 33

°

C and 37

°

C for the flow rates used in

this study. (DUPACO, Incorporated, 1740 LaCosta Meadows Drive, San Maras,
California, 92069.)
Blood Warmer Coil. A Fenwal Blood Warmer Coil with Extension Set
(#4C2403) was used. Fluid was infused through the warming coil which was
immersed in the water reservoir of the DUPACO Hemokinetitherm® in
accordance with the manufacturer's instructions. The Fenwal coil measures
approximately 535 em in total length and contains a volume of approximately 50
ml.

Of the 535 em, approximately 46 em of the tubing is proximal to the coil and

174 em (extension set) is distal to the coil.

(Fenwall Laboratories, Division of

Travenol Laboratories, Incorporated, 1 Baxter Parkway, Deerfield, Illinois,
60015.)
Infusion Pump.

The Travenol Flo-Gard Model 8000 volumetric infusion

pump was used. The Flo-Gard 8000 delivered from 1 ml/hr to 999 ml/hr in 1
ml/hr increments. It was accurate to ± 4 ml/hr at a setting of 125 ml/hr
according to the manufacturer.

(Travenol Laboratories, Incorporated, 1 Baxter

Parkway, Deerfield, Illinois, 60015.)
Volumetric Pump Solution Set.

The Travenol Volumetric Pump Solution

Set (#2C1031) was used. The set measured approximately 270 em in length and
contained a volume of approximately 15 ml distal to the drip chamber.

(Travenol

Laboratories, Incorporated, 1 Baxter Parkway, Deerfield, Illinois, 60015.)
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Temperature Monitorin� System. The Mon-A-Therm® Model 6500
temperature monitoring system was used to measure temperatures at the two sites
in the infusion setup and also to measure room temperature. The Mon-A
Therm® is a two-channel, microprocessor-based, instrument which provides
temperature measurements with a resolution of 0.1
range of 1-50

°

C.

°

C accurate to 0.1

°

C over a

It had a pre-set calibration which was checked each time the

module was turned on.

In this study, all temperature monitors used registered a

calibration number of 100.0 ± 0.2 which indicated proper calibration according to
the manufacturer's specifications.

(Mon-A- Therm®, Incorporated, 520 South

Jefferson Avenue, St. Louis, Missouri, 63103.)
Temperature Monitorin� Probes. There were two types of temperature
probes used in this study. A Mon-A-Therm®, 9 Fr., esophageal stethoscope with
temperature sensor (Catalog #503-0032) was used to measure temperatures in
the intravenous fluid containers. A Mon-A-Therm® luer lock temperature sensor
(Catalog #503-0501) was used to measure delivered temperatures at the distal
end of the infusion set. (Mon-A-Therm®, Incorporated, 520 South Jefferson
Avenue, St. Louis, Missouri, 63103.)

Data Analysis
A two-way analysis of variance (ANOVA) was used to examine the effects
of flow rate and the various methods of temperature maintenance on the
delivered temperature of intravenous crystalloid solutions (group x flow rate).
There were four levels of the group factor (Groups 1, 2, 3, 4) and five levels of
the flow rate factor (100, 250, 500, 750, 1,000 ml/hr).

Chapter Four

Results

A quasi-experimental design was used to determine the effect of the
Thermal Jacket"', compared to conventional means, on the delivered temperature
of prewarmed, crystalloid, intravenous solutions in the operating room
environment.

One control group and three experimental groups were used.

Group 1 was the control group and consisted of prewarmed intravenous fluids
infused using no temperature maintenance device.

Group 2 consisted of

prewarmed IV fluids infused through a water bath type blood warmer.

Group 3

consisted of IV fluids near ambient room temperature and infused through a
water bath type blood warmer.

Group 4 consisted of prewarmed IV fluids

infused using a Thermal Jacket"' insulation device.
Ambient room temperature was measured at 21.0 ± 0.2
controlled.

°

C, but not

Room temperature fluids were determined to be 22.05 ± 0.45

prewarmed fluid were heated to 41.45 ± 1.05

°

C.

°

C and

The mean temperatures of the

fluid containers and the delivered temperatures for each group are shown in
Table 1. The mean temperatures of both the fluid containers and the delivered
temperatures for each flow rate are shown in Table 2.
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A Wilk's multifactor
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Table 1
Temperature of Fluids from Container
to Distal Site by Group'

Temperature (·C)

Group

·

Container

Distal Site

1

36.7 ± 0.45

25.4 ± 0.54

2

37.3 ± 0.46

28.8 ± 0.61

3

21.9 ± 0.05

27.0 ± 0.52

4

39.9 ± 0.18

26.8 ± 0.65

Mean Temperature

±

S.E.M.
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Table 2
Temperature of Fluids from Container
to Distal

Site by Flow Rate'

Temperature (·C)
Flow Rate
(ml/hr)

Container

Distal Site

100

33.6

±

1.40

22.7

±

0.43

250

34.4

±

1.40

25.1

±

0.39

500

33.8

±

1.41

27.4

±

0.53

750

34.0

±

1.43

29.4

±

0.46

1,000

33.8

±

1.40

30.4

±

0.42

·

Mean Temperature

±

S.E.M.
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analysis of variance revealed a highly significant overall group effect, .E( 6, 262)
150.59, p < .0001, as well as a highly significant flow rate effect, .E(8, 262)

=

=

25.27,

p < .0001, on the delivered temperature.

Group Effect
Analysis of variance showed a highly significant group effect on the
delivered temperature.

A

Bonferroni multiple comparisons test was used to

determine which groups were the major contributors. Group 2 had a significantly
higher delivered temperature (12. < .05) than the other groups while Group 1 had a
significantly lower delivered temperature (12. < .05). There was no statistically
significant difference between the delivered temperatures of Group 2 and
Group 3.
Analysis of variance also showed a highly significant group effect on the
temperature in the fluid container (12. < .05).

A

Bonferroni multiple comparisons

test was used to determine which groups were the major contributors to this
effect. Group 4 had a significantly higher temperature than the other groups
(12. < .05) while Group 3 had a significantly lower temperature (12. < .05). There was
no significant difference between the fluid container temperatures in Group 1 and
Group 2.

Flow Rate Effect
Analysis of variance showed a highly significant flow rate effect.

A

Bonferroni multiple comparisons test was used to determine the relationship
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between flow rate and the delivered temperature. A statistically significant
(J;.?. < .05) difference was found between flow rates of 100, 250, 500, and 750 ml/hr,
with the higher flow rates resulting in higher delivered temperatures.

There was

no significant difference, however, between flow rates of 750 and 1,000 ml/hr.
Analysis of variance showed no significant difference between the fluid container
temperatures at the various flow rates.

Chapter Five

Discussion

The purpose of this quasi-experimental study was to determine the
relationship between the flow rate and the delivered temperature of prewarmed,
crystalloid, intravenous solutions when using the Thermal Jacketrw as compared to
a conventional blood warming apparatus.

Hypothesis Testing
There were six hypotheses proposed in this study.

1)

They were as follows:

there will be no difference between the delivered temperatures of

prewarmed and room temperature fluids using a blood warmer apparatus;
2) there will be no difference between the delivered temperatures of room
temperature fluids using a blood warmer apparatus and prewarmed fluids using
no temperature maintenance device;

3)

there will be no difference between the delivered temperatures of room

temperature fluids using a blood warmer apparatus and prewarmed fluids using
the Thermal Jacketrw;
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4) there will be no difference between the delivered temperatures of
prewarrned fluids using a blood warmer apparatus when compared with no
temperature maintenance device;
5) there will be no difference between the delivered temperatures of
prewarrned fluids using the Thermal Jacket"' when compared with no temperature
maintenance device; and
6) there will be no difference between the delivered temperatures of
prewarrned fluids using the Thermal Jacket"' when compared with a blood
warmer apparatus.
Only one of these hypotheses failed to be rejected: there was no significant
difference between the delivered temperatures of room temperature fluids passed
through a blood warming device and prewarmed fluids using the Thermal Jacket"
(Hypothesis 3). The remaining five hypotheses were rejected. There was a
significant difference between the delivered temperatures when comparing the
other group combinations.

Correlation With Previous Studies
This study supports the findings of Baker (1985), Cooter (1987), and Rymers
(1988) that faster flow rates resulted in less heat loss and a higher delivered
temperature. Unlike Baker's findings, at no time did the delivered temperature
fall below the initial temperature of unwarmed fluid. One explanation for this
could be the care taken in avoiding contact between the infusion tubing and any
uninsulated surface. There were no unexplained temperature fluctuations in this
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study as in Cooter's and Ryrners' studies.

Flow rates were not as high in this

study, therefore, only one infusion pump was used for each group.
This study also supported the findings of Norman et al. (1986).

First,

insulation of prewarmed fluids resulted in higher delivered temperatures than
uninsulated fluids.

Second, higher flow rates resulted in higher delivered

temperatures due to a decrease in heat loss.
The delivered temperatures in this study did not match those of Boyan and
Howland (1961).

They reported delivered temperatures as high as 35

rates of 3,000 ml/hr.

°

C at flow

At a flow rate of 1,000 rnl/hr, room temperature fluid

passing through the blood warmer reached a maximum temperature of 30.6

°

C.

This discrepancy could be due to the flow rates or types of fluid compared.
Boyan and Howland used banked blood, whereas, this study used crystalloid fluid.
At slower flow rates, the warmed fluid is exposed to colder ambient room air
longer and would tend to lose more heat.
The results of this study differed from those of Aldrete (1985).

Aldrete

found that preheating, alone, resulted in the highest delivered temperature while
the combination of preheating and blood warmer resulted in a still higher
delivered temperature than the blood warmer alone.

This study found that the

combination of preheating and infusion through a blood warmer resulted in the
highest delivered temperature.

Infusing room temperature fluid through a blood

warmer resulted in temperatures similar to the combination of preheating and
using the Thermal Jacket"'. The obvious difference between the studies was the
length of infusion tubing. In Aldrete's study the length of tubing distal to the
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blood warmer was nearly the same length as the straight infusion set used. In the
current study, the straight tubing was 96 em longer than the tubing distal to the
blood warmer. As Rymers (1988) found, the length of tubing contributes
significantly to the amount of heat loss. If the tubing lengths were identical, the
results may have more closely correlated with Aldrete's.
Aldrete also reported that the fluid in the container cooled more per
volume infused at slower infusion rates. The problem of this reporting was
pointed out previously, it did not account for the length of time the fluid was
exposed to room air.

In the current study, at slower infusion rates, there was a

larger amount of heat lost per volume infused (0.086
compared to 0.007

°

°

C per ml at 100 ml/hr

C at 1000 ml/hr) supporting the earlier criticism, there was

no significant statistical correlation between infusion rates and temperature of
fluid in the container in this study.
Compared to Fried's (1986) study, the methods used in this investigation
were far inferior in maintaining a warm delivery temperature. The difference was
possibly related to the equipment used.

Fried used an extracorporeal heat

exchanger with a large countercurrent waterflow as the heat source. This was a
much more elaborate and expensive setup, and was designed as a rapid solution
administration set for use with mass trauma cases. The methods used in the
current study correspond to more widely used operating room techniques.
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Flow

Rate Effect
There was a highly significant correlation between flow rate and the

delivered temperature.

Higher flow rates resulted in higher delivered

temperatures due, at least in part, to the time the fluid was exposed to the
relatively cooler, ambient room air.

There was an insignificant correlation

between flow rate and the temperature of the fluid in the container.

Group E ffect
There was a highly significant difference between the various groups in
maintaining the temperature of the fluid in the container as well as the delivered
temperature.

The Thermal Jacket'" provided insulation and maintained a higher

temperature of the fluid in the container.

The combination of prewarming and

delivery through a blood warmer resulted in higher delivered temperatures at all
flow rates.

Prewarming fluids and insulating with the Thermal Jacket'" provided

delivery temperatures similar to those of infusing room temperature fluids
through a blood warmer and through a conspicuously shorter length of tubing.
Prewarrning and infusing through a straight infusion set resulted in the lowest
delivered temperatures.

Limitations
The only serious limitation to this study was the length of tubing used with
the various groups. The tubing lengths were chosen to resemble, as closely as
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possible, the clinical situation in which these methods of warming fluids might be
utilized.

Various blood warmers have differences in their effectiveness in

warming fluids over a range of flow rates. This, combined with the broad range
of temperatures at which the fluid can be prewarmed, varying ambient room
temperatures, and combinations of other heat-maintenance maneuvers, limits the
generalizability of this study.

Recommendations for Further Study
The study should be repeated with the following modifications:

1)

Alter the length of the infusion tubing of the straight infusion set to

match that distal to the blood warmer.

2)

Vary room temperature to both extremes to quantify the room

temperature effect on heat loss.
3)

Manipulate the flow rates over a larger range.

4)

Insulate the infusion tubing to further decrease heat loss to ambient

room air.
The Thermal Jacket"' should also be investigated in the clinical setting.
Patients could be divided into 3 groups.

One group could have room

temperature fluids infused throughout their surgery. Another group could have
fluids delivered via a conventional blood warming device. A third group could
have fluids prewarmed and delivered using the Thermal Jacket"'.
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Conclusion
In the setting studied, the Thermal Jacket"' was an effective means of
delivering prewarmed, crystalloid, intravenous fluid via a straight infusion set.
This could be an advantage in situations where a blood warming device may not
be available or the high resistance to flow in the blood warming coil may impede
administration of fluids at desired flow rates. Though using the blood warmer
with prewarmed fluids was more effective in this study, this difference may be
reduced by shortening the length of intravenous tubing used in conjunction with
the Thermal Jacket"'. Additional studies of the Thermal Jacket"', as outlined, may
clarify the advantages of each method.
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